However, inhibition of PI3K/Akt or MEK/ERK signaling pathway has been shown to induce the activation of multiple receptor tyrosine kinases (RTKs) that reactivate the pathway which attenuates its anti-tumor effects [41, 47]. The gene discussed is NTRK1; the disease is neoplasm.